文献速递中毒与环境急症消化、代谢与肾脏急症

鹅膏蕈碱中毒:治疗对临床结局的影响——40年报告病例回顾

Amanitin intoxication: effects of therapies on clinical outcomes - a review of 40 years of reported cases.
PubMed 文献 · Clin Toxicol (Phila) · 2022-09-21
一句话结论系统综述877例含鹅膏蕈碱蘑菇中毒病例:总生存率84%,单用水飞蓟宾或青霉素及NAC/水飞蓟宾联合似乎与较单纯支持治疗更高的生存率相关。

该研究为系统综述,检索MEDLINE和Embase,纳入131篇文献共877例含鹅膏蕈碱鹅膏菌中毒病例,提取临床特征、治疗细节和结局,用中毒严重程度评分(PSS)肝脏条目分级。总生存率84%,仅支持治疗者生存率59%;单用水飞蓟宾(SIL)或青霉素(PEN)者生存率分别为90%(OR 6.40 [3.14-13.04])和89%(OR 5.24 [2.87-9.56]),NAC/SIL联合为85%(OR 3.85 [2.04, 7.25]),NAC/PEN/SIL组为76%(OR 2.11 [1.25, 3.57])。在经证实的鹅膏蕈碱中毒病例中,NAC、PEN或SIL的效应未见统计学差异。无移植存活者AST、ALT、总胆红素和INR峰值显著低于肝移植存活者和死亡患者,PSS峰值越高死亡率越高。

要点

  • 877例含鹅膏蕈碱蘑菇中毒总生存率84%,仅支持治疗者生存率59%。
  • 单用SIL生存率90%(OR 6.40 [3.14-13.04]),单用PEN生存率89%(OR 5.24 [2.87-9.56]),均高于仅支持治疗。
  • NAC/SIL联合生存率85%(OR 3.85 [2.04, 7.25]),NAC/PEN/SIL联合生存率76%(OR 2.11 [1.25, 3.57])。
  • 在经证实(检出鹅膏蕈碱)中毒中,NAC、PEN或SIL的效应未观察到统计学差异。
  • 无移植存活者AST、ALT、总胆红素和INR峰值显著低于肝移植存活者和死亡患者,PSS峰值越高死亡率越高。

适用人群与场景

  • 纳入描述含鹅膏蕈碱鹅膏菌中毒后患者结局的病例系列和病例报告。
  • 按鹅膏蕈碱检测和蘑菇鉴定分为经证实病例(检出鹅膏蕈碱)、很可能病例(真菌学家鉴定蘑菇)和可能病例(既未检出鹅膏蕈碱也未鉴定蘑菇)。

诊断标准与关键阈值

  • 采用中毒严重程度评分(PSS)中的肝脏条目对中毒严重程度进行分类。

处置流程与药物剂量

  • 研究评估的疗法包括N-乙酰半胱氨酸(NAC)、青霉素(PEN)和水飞蓟宾(SIL),但原文未给出具体剂量、给药途径和疗程。

红旗征与不能漏的情况

  • 无移植存活者的AST、ALT、总胆红素(TSB)和INR峰值显著低于肝移植存活者和死亡患者,上述指标峰值升高提示可能致命结局。
  • PSS峰值越高与死亡率增加相关。

研究设计与关键结果

  • 系统综述纳入131篇文献共877例含鹅膏蕈碱蘑菇中毒病例,总生存率84%。
  • 仅接受支持治疗者生存率59%;单用SIL者生存率90%(OR 6.40 [3.14-13.04]),单用PEN者生存率89%(OR 5.24 [2.87-9.56])。
  • NAC/SIL联合治疗者生存率85%(OR 3.85 [2.04, 7.25]),NAC/PEN/SIL联合治疗者生存率76%(OR 2.11 [1.25, 3.57])。
  • 因病例数有限,单用NAC的效应无法评估。
  • 在经证实病例、很可能病例和可能病例中的补充分析显示结果相当,但未达统计学显著。
  • 无移植存活者的AST、ALT、TSB和INR峰值显著低于肝移植存活者和死亡患者;PSS峰值越高与死亡率增加相关。

证据类型、等级与局限

  • 证据类型:系统综述(病例系列和病例报告)。
  • 局限:因病例数有限,单用NAC的效应无法评估;在经证实、很可能和可能病例中的补充分析结果未达统计学显著。

对床旁实践的改变

  • 作者认为,基于现有数据,在经证实的含鹅膏蕈碱蘑菇中毒中,NAC、PEN或SIL的效应未观察到统计学差异;但单用SIL或PEN以及NAC/SIL联合治疗似乎与较单纯支持治疗更高的生存率相关。
  • AST、ALT、TSB和INR值可能是潜在致命结局的预测指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND AIMS: Amanita phalloides poisoning causes severe liver damage which may be potentially fatal. Several treatments are available, but their effectiveness has not been systematically evaluated. We performed a systematic review to investigate the effect of the most commonly used therapies: N-acetylcysteine (NAC), benzylpenicillin (PEN), and silibinin (SIL) on patient outcomes. In addition, other factors contributing to patient outcomes are identified.

METHODS: We searched MEDLINE and Embase for case series and case reports that described patient outcomes after poisoning with amanitin-containing Amanita mushrooms. We extracted clinical characteristics, treatment details, and outcomes. We used the liver item from the Poisoning Severity Score (PSS) to categorize intoxication severity.

RESULTS: We included 131 publications describing a total of 877 unique cases. The overall survival rate of all patients was 84%. Patients receiving only supportive care had a survival rate of 59%. The use of SIL or PEN was associated with a 90% (OR 6.40 [3.14-13.04]) and 89% (OR 5.24 [2.87-9.56]) survival rate, respectively. NAC/SIL combination therapy was associated with 85% survival rate (OR 3.85 [2.04, 7.25]). NAC/PEN/SIL treatment group had a survival rate of 76% (OR 2.11 [1.25, 3.57]). Due to the limited number of cases, the use of NAC alone could not be evaluated. Additional analyses in 'proven cases' (amanitin detected), 'probable cases' (mushroom identified by mycologist), and 'possible cases' (neither amanitin detected nor mushroom identified) showed comparable results, but the results did not reach statistical significance. Transplantation-free survivors had significantly lower peak values of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total serum bilirubin (TSB), and international normalized ratio (INR) compared to liver transplantation survivors and patients with fatal outcomes. Higher peak PSS was associated with increased mortality.

CONCLUSION: Based on data available, no statistical differences could be observed for the effects of NAC, PEN or SIL in proven poisonings with amanitin-containing mushrooms. However, monotherapy with SIL or PEN and combination therapy with NAC/SIL appear to be associated with higher survival rates compared to supportive care alone. AST, ALT, TSB, and INR values are possible predictors of potentially fatal outcomes.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Tan JL, Stam J, van den Berg AP, et al. Amanitin intoxication: effects of therapies on clinical outcomes - a review of 40 years of reported cases. Clin Toxicol (Phila). 2022. PMID: 36129244. doi:10.1080/15563650.2022.2098139

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。